Northwestern Mutual Wealth Management
CORT icon

Northwestern Mutual Wealth Management’s Corcept Therapeutics CORT Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-156
Closed -$5.43K – 4192
2025
Q4 		$5.43K Buy
156
+145
+1,318% +$11.4K ﹤0.01% 3201
2025
Q3 		$914 Buy
+11
New +$796 ﹤0.01% 3568
2024
Q4 		– Sell
-72
Closed -$3.33K – 3659
2024
Q3 		$3.33K Buy
+72
New +$2.56K ﹤0.01% 3010
2024
Q1 		– Sell
-20
Closed -$650 – 3608
2023
Q4 		$650 Buy
+20
New +$549 ﹤0.01% 3240
2022
Q3 		– Sell
-50
Closed -$1K – 3161
2022
Q2 		$1K Buy
+50
New +$1.09K ﹤0.01% 3013
2018
Q4 		– Sell
-115
Closed -$2K – 2421
2018
Q3 		$2K Sell
115
-2,172
-95% -$30.4K ﹤0.01% 2262
2018
Q2 		$36K Buy
+2,287
New +$39.8K ﹤0.01% 1369

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Northwestern Mutual Wealth Management's CORT Position: Q1 2026 in Review

Northwestern Mutual Wealth Management sold out of Corcept Therapeutics (CORT) in Q1 2026, closing a stake of 156 shares — an estimated $5.43K sold.

Northwestern Mutual Wealth Management first reported a position in CORT in Q2 2018 and held it in 7 quarters. The position peaked at $36K in Q2 2018. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

  • Northwestern Mutual Wealth Management reported no remaining Corcept Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 156 Corcept Therapeutics shares in Q1 2026, an estimated $5.43K.
  • Northwestern Mutual Wealth Management first reported a position in Corcept Therapeutics in Q2 2018 and held it in 7 quarters.
  • Northwestern Mutual Wealth Management's Corcept Therapeutics position peaked at $36K in Q2 2018.
  • 351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.